Advertisment

RecoMed Secures Major Funding for Digital Healthcare in Oncology and Neurology from Eisai

RecoMed, South Africa's leading online healthcare marketplace, partners with Eisai to innovate patient care in oncology and neurology, marking a significant digital transformation.

author-image
Israel Ojoko
New Update
RecoMed Secures Major Funding for Digital Healthcare in Oncology and Neurology from Eisai

RecoMed Secures Major Funding for Digital Healthcare in Oncology and Neurology from Eisai

RecoMed, South Africa's leading online healthcare marketplace, has announced its largest funding round to date, marking a significant milestone in the digital healthcare sector. This investment by Eisai, a global pharmaceutical giant, aims to revolutionize patient care, particularly focusing on oncology and neurology, with an initial emphasis on breast cancer. Sheraan Amod, RecoMed's CEO, and Shin Ujiie, Eisai's vice-president for corporate strategy, highlight the shared vision of leveraging digital platforms to enhance healthcare accessibility and patient journeys.

Advertisment

Strategic Investment to Transform Healthcare

The partnership between RecoMed and Eisai is poised to create a groundbreaking digital patient healthcare journey. With over 100,000 bookings managed monthly, RecoMed's platform connects healthcare practitioners and patients, facilitating easier access to medical services. The investment will be channeled into enhancing RecoMed's technology, driving platform awareness, and building a robust digital healthcare journey, with breast cancer as the initial focus area. This collaboration underscores the shared commitment of RecoMed and Eisai to improve patient treatment outcomes and streamline the healthcare experience.

Expanding Digital Health Services

Advertisment

RecoMed's innovative approach to digital health services has established it as a leader in the healthcare sector. The platform collaborates with pharmacies, clinics, primary care, and hospital groups, offering a white-label solution for bookings and telehealth appointments. The introduction of an e-pharmacy service further exemplifies RecoMed's commitment to simplifying patient care, enabling users to upload prescriptions and choose between collecting their medications from participating pharmacies or having them delivered. This strategic expansion of services, powered by Eisai's investment, aims to facilitate over R500 million in healthcare spend annually, simplifying patient care for more than 1.5 million users.

A Vision for Accessible Healthcare

Eisai's entry into the African market and its investment in RecoMed signal a transformative shift towards making healthcare more accessible. The collaboration aligns with Eisai's goal of using digital platforms to alleviate health-related anxieties and reduce disparities in healthcare access. By focusing on digital solutions to streamline the patient journey, RecoMed and Eisai are set to make significant strides in improving healthcare delivery, setting a new standard for patient care in South Africa and potentially beyond.

This partnership between RecoMed and Eisai not only represents a significant financial investment in the future of healthcare but also a commitment to leveraging technology to address critical healthcare needs. As RecoMed embarks on this ambitious journey to enhance digital healthcare pathways, particularly in the realms of oncology and neurology, the potential for improved patient outcomes and more efficient healthcare delivery is immense. The success of this collaboration could pave the way for further innovations in digital health services, ultimately contributing to a healthier, more accessible healthcare system for all.

Advertisment
Advertisment